Skip to content

CI

Cigna

NYSEHealth CareHealthcare PlansSnapshot 2026-05-08

$288.06+1.42%
Close 2026-05-08 · 1-day change
The bottom line

As of May 8, 2026, CI has a composite score of 24.8, categorized as "mild favorable." This score is influenced by a medium confidence level of 76.1 and reflects various factors, including a macro score of 31.5 and a management score of 75.1. The analysis is provisional and highlights risks related to labor, rates, and sector trends.

Composite +25as of 2026-05-08

Price

Daily closes from AlphaVantage. Earnings/event dots are placed inline.

Close 2026-05-08
Daily closes. Scroll over the chart to zoom; click a range to reset.
EarningsMaterial event

Factor signals

Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.

L1

Thesis

is this a strong company over a 1–3 year hold?
F1 · Recent financial performance
neutral
Mid-cohort
Why this rank
  • Direction share
    1.00
  • Slope (norm)
    0.01
  • Bonus
    0.00
Operating income, last 4 quarters ($M)
2256230625782277
F2 · Value
cheap
Cheapest 30% of health care cohort
Why this rank
Price
$288.06
TTM EPS
$14.35
Earnings yield
5.0%
P/E (TTM)
20.1

Trailing four: 2024-Q3, 2025-Q1, 2025-Q2, 2025-Q3

F3 · Earnings quality
Insufficient data
No score yet
L2

Watch

has something changed worth re-reading?
F4 · Management stability
volatile
Bottom 10% activity in health care cohort· see deep-dive ↓
capital friendlyTop 10% capital-friendly in health care cohort
Earnings setup · pre-print positioning
forward-looking
bullish strong6 PT revisions / 30d, avg 18.5% above currentfor period ending 2026-06-30
Why this setup
Consensus revisions

EPS estimate $7.39 → $7.56 (+2.3% / 30d). 12 raised, 2 cut, 21 covering analysts.

Rating actions

0 upgrades, 0 downgrades / 30d, 7 maintained. 92% of analysts rate Buy.

Price target activity

6 PT revisions / 30d. Avg target 18.5% above current price.

Material events

0 positive, 0 negative / 30d.

F4 · Management deep-dive — recent events, stated priorities, guidance track record
2

Stated priorities

3 priorityies extracted from earnings transcripts (as of 2026-05-08).

  1. 1.Increase adjusted income from operationsgrowthmixed65% progress
    2/27: The Cigna Group officials expect to reaffirm projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share.
    Why this status

    Stated in 5 of last 5 quarters. The guidance for adjusted income from operations increased from $29.60 per share in 2025 to at least $30.35 per share in 2026. Despite the increase in guidance, the status remains behind, indicating limited progress in achieving the target.

  2. 2.Achieve Cigna Healthcare income targetgrowthbehind14% progress
    3/3: Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.
    Why this status

    Newly stated in 2026-Q1. The target for Cigna Healthcare pre-tax adjusted income from operations is set at $4.5 billion. However, the status is behind, indicating that the company has not yet achieved this target.

  3. 3.Reach adjusted revenue goalgrowthbehind14% progressprovisional
    2/5: The Cigna Group's outlook for full year 2026 adjusted revenues is approximately $280.0 billion.
    Why this status

    Newly stated in 2026-Q1. The company has set an adjusted revenue goal of approximately $280.0 billion for 2026. The status is behind, suggesting that the company is not yet on track to meet this revenue target.

3

Guidance track record

Insufficient guidance history for this ticker.

L3

Position context

how violent might the path be while I hold it?
Risk profile · realized
backward-looking
moderateworst 12m loss −27%, typical day ±1.3%
Why this risk level

Recent vol — 30d annualized 26%; 252d 34%.

Drawdown — Max 1y −27%. Bad day move −3%.

Beta to sector ETF (XLV) 0.79 over 1y.

Liquidity — score 100/100.

Sub-scores — vol 43/100, drawdown 47/100, beta 79/100, earnings vol .

Calm + bullish setup — clean pre-earnings positioning pattern.

Sector regime
headwind-15.1%sector vs S&P 500, 60d

via XLV

Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.

AI cycle regime · market-wide
2-axis classifier
HeatingManiaSquallCrisisEarnings →Mood ↑
HeatingE +0.13 · M +0.71
Single-axisCHASEz +2.97+1.285d

Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.

Not investment advice. As of 2026-05-08.

3

What changed

The most important moves since the prior daily snapshot.

  1. No material changes since the prior snapshot.

No material changes since the prior snapshot.

as of 2026-05-08

4

Management scorecard

How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.

Composite75.1 / 100
Capital allocation94
Earnings discipline72
Margin discipline70
Balance sheet50
Guidance credibility
Post-call reaction52
as of 2026-05-08
4

What management is focused on

Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.

  • #1

    Increase adjusted income from operations

    GrowthNew since 2026-05-04

    Focus on increasing adjusted income from operations to meet or exceed guidance.

    BehindMixed

    Stated in 5 of last 5 quarters. The guidance for adjusted income from operations increased from $29.60 per share in 2025 to at least $30.35 per share in 2026. Despite the increase in guidance, the status remains behind, indicating limited progress in achieving the target.

    65%
    CEO/CFO:The Cigna Group officials expect to reaffirm projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share.
    8-KSource dated 2026-02-27Stated 5 of last 8 quartersFirst seen 2026-05-04
    Show history (5)
    • 2026-Q18-K

      2026 outlook for adjusted income from operations increased to at least $30.35 per share

    • 2025-Q48-K

      Reaffirms 2025 outlook for adjusted income from operations of at least $29.60 per share

    • 2025-Q38-K

      Reaffirms 2025 outlook for adjusted income from operations of at least $29.60 per share

    • 2025-Q28-K

      Reaffirms 2025 outlook for adjusted income from operations of at least $29.60 per share

    • 2025-Q18-K

      The Cigna Group's outlook for full year 2025 consolidated adjusted income from operations is $29.60 per share.

  • #2

    Achieve Cigna Healthcare income target

    GrowthNew since 2026-05-04

    Aim to achieve the Cigna Healthcare pre-tax adjusted income from operations target.

    Behind

    Newly stated in 2026-Q1. The target for Cigna Healthcare pre-tax adjusted income from operations is set at $4.5 billion. However, the status is behind, indicating that the company has not yet achieved this target.

    14%
    CEO/CFO:Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.
    8-KSource dated 2026-03-03Stated 1 of last 8 quartersFirst seen 2026-05-04
    Show history (1)
    • 2026-Q18-K

      Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.

  • #3

    Reach adjusted revenue goal

    GrowthNew since 2026-05-04

    Strive to reach the full year 2026 adjusted revenue goal.

    Behind

    Newly stated in 2026-Q1. The company has set an adjusted revenue goal of approximately $280.0 billion for 2026. The status is behind, suggesting that the company is not yet on track to meet this revenue target.

    14%
    CEO/CFO:The Cigna Group's outlook for full year 2026 adjusted revenues is approximately $280.0 billion.
    8-KSource dated 2026-02-05Stated 1 of last 8 quartersFirst seen 2026-05-04provisional
    Show history (1)
    • 2026-Q18-K

      The Cigna Group's outlook for full year 2026 adjusted revenues is approximately $280.0 billion.

as of 2026-05-08
5

How this stock is priced

Two ways to read price: against peers in the same business, and against the company's own history.

Compared to peers
92higher = cheaper

Looks cheaper than most peers in the same business.

Compared to its own history
higher = cheaper

Self-history needs ~20 months of data.

P/E
9.2x
EV/EBITDA
7.1x
FCF yield
10.1%

P/E over the last 5 years

0 monthly points
Self-history needs ~20 months of TTM data; this ticker isn’t there yet.
inexpensiveas of 2026-05-08
7

How this compares

A side-by-side read on composite, valuation, and risk versus peers.

StockCompositeValuationRisk
CI
Cigna
+25inexpensivemoderate
LLY
Lilly (Eli)
+21fullmoderate
JNJ
Johnson & Johnson
+18fulllow
ABBV
AbbVie
+12fairlow
UNH
UnitedHealth Group
+24fairelevated
8

Risk — how this stock moves

What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.

A typical day
How much price usually moves either way.
1.3%
A bad day (95th %ile)
A rough but not unusual down day.
-2.6%
Worst 12-month loss
Deepest peak-to-trough drop in the last year.
-26.6%
Earnings-day move
How much price usually moves on earnings day.
moderateas of 2026-05-08
9

What could change this view

Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.

Upside triggers
  • If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
Downside triggers
  • If next-quarter guidance is cut (currently RAISED as of 2026-04-30)-16 pts
  • If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
  • If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
  • If rates state reverses from -0.37 (negative) to +0.37 (positive)-2.9 pts
10

Material updates

Recent SEC 8-K filings ranked by likely impact, confidence, and recency.

  1. 2026-04-308d agoItem 2.02

    Results of Operations and Financial Condition. On April 30, 2026, The Cigna Group issued a press release announcing results for the three months ended March 31, 2026. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities A…

    earnings preannouncementneutralscore 54
  2. 2026-03-032mo agoItem 5.02

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Chief Executive Officer Succession On February 25, 2026, the Board of Directors (the “Board”) of The Cigna Group (the “Company”) appointed Mr. Brian C. Evanko as Chief Executive Officer (“CEO”) of the Company, effective July 1, 2026. Mr. Evanko will succeed Mr. David M. Cordani, who will retire as the CEO of the Company effective July 1, 2026. Mr.…

    executive changeneutralscore 17
  3. 2026-03-032mo agoItem 7.01

    Regulation FD Disclosure. The Company is reaffirming projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share. The Company is also reaffirming 2026 Evernorth pre-tax adjusted income from operations of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion. The Cigna Group previously discussed its full year 2026 outlook in its press release dated February 5, 2026, and during the related investor con…

    mna activitypositivescore 11
  4. 2026-02-272mo agoItem 7.01

    Regulation FD Disclosure. 2026 Outlook Affirmation The Cigna Group (or “our”) officials expect to participate in meetings with investors and analysts over the next several weeks. During these meetings, The Cigna Group officials expect to reaffirm projected full year 2026 consolidated adjusted income from operations on a per share basis of at least $30.25 per share. The Cigna Group previously discussed its full year 2026 outlook in its press release dated February 5, 2026, and during the relat…

    mna activitypositivescore 10
  5. 2026-02-053mo agoItem 2.02

    Results of Operations and Financial Condition. On February 5, 2026, The Cigna Group issued a press release announcing results for the three months and year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under th…

    earnings preannouncementneutralscore 8
11

Score history

The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.

60 snapshots
Data freshness · As of 2026-05-08 · Macro 2026-05-08 · Sector 2026-05-07 · Fundamentals 2026-02-26 · Price 2026-05-07 · Generated 2026-05-08 · Spec 2.3

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.